Jason Tardio - 12 Sep 2022 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Chief Operating Officer
Signature
/s/ Danielle Mann for Jason Tardio by PoA
Issuer symbol
OVID
Transactions as of
12 Sep 2022
Net transactions value
-$37,290
Form type
4
Filing time
14 Sep 2022, 16:58:34 UTC
Previous filing
12 Apr 2022
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OVID Common Stock Sale $37,290 -17,344 -100% $2.15 0 12 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired the shares pursuant to the Issuer's employee stock purchase plan. These transactions were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Following the reported transaction, the Reporting Person will hold no ESPP shares.